書籍詳細

●第1章 全体像を把握する

P.16 掲載の参考文献

• 1) 岡田了三:心臓の形態学. Post-graduate guidance(1). 心臓1970;2:1069-1083.

• 2) 岡田了三:心臓の組織学. Post-graduate guidance(2). 心臓1970;2:1183-1197.

• 3) Smith JJ, et al:循環の生理. 第2版. 村松準監訳. 東京:医学書院;1994. p.21-346.

• 4) Rushmer RF:Cardiovascular dynamics. 4th ed. Philadelphia, London, Toronto;W. S. Saunders Co;1976. p.1-567.

• 5) 山田和生監修:最新心電図・ベクトル心電図学. 第1版. 東京:メディカル出版;1978. p.13-831.

• 6) 伊藤隆:組織学. 18版. 東京:南山堂;1987. p.151-171.

• 7) 松尾寿之ら:臨床からみた生理活性物質. 特集. ナノギガ1993;2:15-159.

P.26 掲載の参考文献

• 1) 矢崎義雄:心臓病の病態生化学. 東京:南江堂;1995.

• 2) 戸田昇, 我孫子保:循環系治療薬の作用メカニズム. 東京:南江堂;1998.

• 3) Opie LH:The heart physiology from cell to circulation. 3rd ed. philadelphia:Lippincott-Raven;1998.

P.53 掲載の参考文献

• 1) 斉藤宗靖編:循環器病の薬物療法. 目でみる循環器病シリーズ13. 東京:メジカルビュー社;1998.

P.61 掲載の参考文献

• 1) Theroux P, et al:Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med(1988)319:1105-1111.

• 2) http://www.ebm-library.jp/circ/index_top.html

P.67 掲載の参考文献

• 1) 平野恭子:検証脳死・臓器移植. 岩波ブックレットNo.497, 東京:岩波書店;2000.

• 2) 松田暉ほか:臓器移植法制定後初めて行なわれた脳死からの臓器移植. 心臓移植症例報告. 日本醫事新報1999;3925:20-23.

• 3) 蓮尾裕:久山町住民における急死例の臨床疫学的研究. 福岡医学雑誌1987;78:164-180.

• 4) 徳留省悟ほか:大都市市民の突然死. 診断と治療1991;79:267-272.

• 5) 村山正博:心臓性急死の実態と機序. 日本醫事新報1992;3579:3-14.

●第2章 検査の目的と結果のよみ方

P.76 掲載の参考文献

• 1) Alpert JS, et al:Manual of cardiovascular diagnosis and therapy. 4th ed. Boston:Little, Brown and Company;1996.

• 2) Marso SP, et al editors:Manual of cardiovascular medicine. New York:Lippincott Williams & Wilkins;2000.

• 3) Sharis PJ, et al:Evidence-based cardiology. New York:Lippincott Williams & Wilkins;2000.

• 4) Antman EM:General hospital management. In:Julian DG, et al editors. Management of acute myocardial infarction. London:WB Saunders Ltd;1994. p.63.

P.106 掲載の参考文献

• 1) 谷川直:Holter心電図. 永井良三ら編. 循環器研修医ノート. 東京:診断と治療社;1997. p.226-230.

• 2) 谷川直:ホルター心電図の解析レポート. 臨床検査1988;32:220-222.

• 3) Harold LK:Ambulatory electrocaridiography. Philadelphia:Lea and Febiger;1981.

• 4) 岡島光治:長時間心電図の臨床. 東京:南山堂;1985.

• 5) Crawford MH, et al:ACC/AHA Guidelines for ambulatory electrocardiography. J Am Coll Cardiol 1999;34(3):912-948.
  pubmed

• 6) Knoebel SB, et al:Guidelines for ambulatory elctrocardiography. J Am Coll Cardiol 1989;13:249-258.

P.115 掲載の参考文献

• 1) Gibbons RJ, et al:ACC/AHA guidelines for exercise testing:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 1997;30:260-315.

• 2) Fletcher GF, et al:Exercise standards:a statement for healthcare professionals from the American Heart Association Writing Group. Special Report. Circulation 1995;91:580-615.

• 3) Schlant RC, et al:Guidelines for exercise testing:a report of the Joint American College of Cardiology/American Heart Association Task Force on assessment of cardiovascular procedures. Circulation 1986;74:653A-667A.

P.124 掲載の参考文献

• 1) 西村恒彦:心筋SPECTの新しい展開. 東京:南江堂;1994.

• 2) 杉原洋樹:心臓核医学の21世紀への展望. 東京:メジカルセンス;1999.

• 3) 外山卓二:心臓シンチグラム. 循環器研修ノート. 永井良三編. 東京;診断と治療社;1997, p.263-265.

• 4) Rigo P, et al:Value and limitation of segmental myocardial imaging for localization of coronary artery disease. Circulation 1980;61:973-981.
  pubmed

• 5) Tamaki N, et al:Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease. J Nucl Med 1994;35:594-600.
  pubmed

• 6) Hashimoto T, et al:Significance of technetium-99m/thallium-201 overlap on simultaneously dual emission computed tomography in acute myocardial infarction. Am J Cardiol 1988;61:1181-1186.
  pubmed

• 7) Nishimura T, et al:Radionuclide assessment of stunned myocardium by alternations in perfusion, metabolic and function. Jpn Circ J 1991;55:913-918.

• 8) 外山卓二ら:Hibernating myocardiumの心機能改善と心筋脂肪酸代謝との関連性. 核医学1996;33:607-615.

• 9) Toyama T, et al:Cardiac sympathetic activity estimated by I-123 metaiodobenzylguanidine myocardial imaging in patients with dilated cardiomyopathy after β-blocker or ACE inhibitor therapy. J Nucl Med 1999;40:217-223.

• 10) Germano G, et al:Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-2147.
  pubmed

P.134 掲載の参考文献

• 1) グロスマン・ベイム:心臓カテーテル検査・造影・治療法. 芹沢剛監訳. 原書4版, 東京:南江堂;1993.

• 2) Baim DS, et al:Cardiac catheterization, angiography, and intervention. 5th ed. Baltimore:Williams & Wilkins;1996.

• 3) 平盛勝彦監修, 市田聡編集:心臓カテーテル検査とモニタリング. 東京:メディカ出版;1995.

• 4) AHA Committee Report:A reporting system on patients evaluated for coronary artery disease. Circulation 1975;51:5.

P.140 掲載の参考文献

• 1) Scherlag BJ, et al:Catheter technique for recording His bundle activity in man. Circulation 1969;39:13.
  pubmed

• 2) Josephson ME, et al:Clinical cardiac electrophysiology. In:Techniques and interpretation. 2nd ed. Philadelphia:Lea and Febiger;1993.

• 3) ACC/AHA Task Force:Guidelines for EP and catheter ablation procedures. Circulation 1995;92:673-691.

• 4) Igor Singer, et al:Clinical manual of electrophysiology. New York:Williams & Wilkins, 1993.

●第3章 どんな疾患があるのか

P.147 掲載の参考文献

• 1) Berger PB, et al:Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries(GUSTO-I)trial. Circulation 1997;96:122-127.
  pubmed

• 2) Califf RM, et al:Cardiogenic shock. New Engl J Med 1994;330:1724-1730.
  pubmed

• 3) Harnarayan C, et al:Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J 1970;285:133-137.

• 4) Swan HJC, et al:Hemodynamic spectrum of myocardial infarction and cardiogenic shock. Circulation 1972;45:1097-1110.

• 5) Goldberg RJ, et al:Temporal trends in cardiogenic shock complicating acute myocardial infarction. New Engl J Med 1999:340:1162-1168.
  pubmed

• 6) Menon V, et al:Management of cardiogenic shock complicating acute myocardial infarction. Heart 2002;88:531-537.
  pubmed

• 7) ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction-Executive Summary. Circulation 2004;110:588-636.
  pubmed

• 8) Anderson RD, et al:Use of intraaortic counterpulsation in patients presenting with cardiogenic shock:Observations from the GUSTO-I study. J Am Coll Cardiol 1997;30:708-715.
  pubmed

P.159 掲載の参考文献

• 1) Ho KKL:The epidemiology of heart failure:the Framingham Study. J Am Coll Cardiol 1993;22(Suppl A):6A.

• 2) Guidelines for the Evaluation and Management of Heart Failure:report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline(Committee on Evaluation and Management of Heart Failure). Circulation 1995;92:2764.

• 3) Pitt B, et al. for the Randomized Aldactone Evaluation Study Investigators:The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999;341:709.
  pubmed

• 4) Packer M, et al. for the US Carvedilol Heart Failure Study Group:Effect of carvedilol on morbidity and mortality in chronic heart failure. N Engl J Med 1996;334:1349.

• 5) Granger CB, et al:Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors:the CHARM-Alternative trial. Lancet 2003;362:772.
  pubmed

• 6) McMurray JJ, et al:Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors:the CHARM-Added trial. Lancet 2003;362:767.
  pubmed

• 7) Echt DS, et al:Mortality and morbidity in patients receiving encainide, flecainide, or placebo:the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324:781.

P.190 掲載の参考文献

• 1) White PD:Heart disease. 4th ed. New York;Macmillan Comp.1956. p.537.

• 2) Matthews MB:Historical background. In;Julian DG editor Angina pectoris;Edinbourgh, London and New York:Churchill Livingstone;1977. p.1.

• 3) Gruntzig AR, et al:Nonoperative dilatation of coronary artery stenosis:percutaneous transluminal angioplasty. N Engl J Med 1979;301:61-68.
  pubmed

• 4) Topol EJ:Textbook of cardiovascular medicine. Philadelphia:Lippincott-Raven;1998. p.334.

• 5) Scandinavian simvastatin survival study group:Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease;the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.

• 6) Sacks FM, et al:The effects of pravastatin on coronary events after myocardial infarction in patients with average cholesterol level.:cholesterol and recurrent events trial investigators:N Engl J Med 1996;335:1001-1009.

• 7) Ryan AR, et al:Guideline for percutaneous transluminal coronary angioplasty―a report of the American College of Cardiology/ American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedure (committee on percutaneus transluminal coronary angioplasty). J Am Coll Cardiol 1993;22:2033-2045.

• 8) Calafiore AM, et al:Left anterior descending coronary grafting via anterior small thoracotomy without cardiopulmonary bypass. Ann Thorac Surg 1996;61:1658-1665.
  pubmed

• 9) Horvath KA, et al:Transmyocardial laser revascularization:results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. J Thorac Cardiovascular Sur 1997;113:645-654.

P.199 掲載の参考文献

• 1) 厚生統計協会:国民衛生の動向2002;49:47-54.

• 2) Fuster V, et al:The pathogenesis of acute coronary syndromes (first of two parts). N Engl J Med 1992;326:242-250.

• 3) Reimer KA, et al:The wavefront phenomenon of ischemic cell death, 1:myocardial infarct size vs duration of coronary occlusion of dogs. Circulation 1977;56:786-794.
  pubmed

• 4) Killip T, et al:Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol 1967;20:457-464.

• 5) Forrester JS, et al:Correlative classification of clinical and hemodynamic function after myocardial infarction. Am J Cardiol 1977;39:137-145.
  pubmed

• 6) Fillmore SJ, et al:Arterial oxygen tension in acute myocardial infarction:serial analysis of clinical state and blood gas change. Am Heart J 1970;79:620-629.
  pubmed

• 7) Harnarayan C, et al:Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J 1970;32:728-732.
  pubmed

• 8) Ryan TJ, et al:ACC/AHA guidelines for the management of patients with acute myocardial infarction. J Am Coll Cardiol 1996;28:1328-1428.
  pubmed

• 9) Michels KB, et al:Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 1995;91:476-485.

• 10) Epstein AE, et al:Mortality following ventricular arrhythmia suppression by ecainide, flecainide, and moricizine after myocardial infarction:the original design concept of the cardiac arrhythmia suppression trial (CAST). JAMA 1993;270:2451-2455.
  pubmed

P.208 掲載の参考文献

• 1) Cohn PF:Asymptomatic coronary artery disease. Mod Concepts Cardiovasc Dis 1993;50:55-60.

• 2) 三浦傳ら:無症候性心筋虚血の病型別臨床と頻度統計. 日本臨牀1994;52:496-505.

• 3) Lagerqvist B, et al:Adenosine induced chest pain―A comparison between intracoronary bolus injection and steady state infusion. Cardiovasc Res 1992;26;810-814.

• 4) Pepine CJ, et al:Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The atenolol silent ischemia study(ASIST). Circulation 1994;90:762-768.
  pubmed

• 5) DiBianco R, et al:Amlodipine combined with beta blockade for chronic angina:Results of a multicenter, placebo-controlled, randomized double-blind study. Clin Cardiol 1992;15:519-524.
  pubmed

• 6) Frishman WH, et al:Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. Am J Cardiol 1999;83:507-514.
  pubmed

• 7) Yusuf S, et al:Primary and secondary prevention of myocardial infarction and strokes:An update of randomly allocated, controlled trials. J Hypertens 1993;11(suppl 4):S61-S73.

• 8) Davies RF, et al:Asymptomatic cardiac ischemic pilot(ACIP)study two-year follow-up. Outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 1997;95:2037-2043.
  pubmed

P.211 掲載の参考文献

• 1) 北原博人ら:心臓弁膜症の外科治療. 循環器疾患最新の治療 '96 〜'97. 東京:南江堂;1996. p.143-147.

• 2) 佐藤滋ら:僧帽弁閉鎖不全症の開心術前後の運動耐容能の変化. 理学療法学1996;26(2):43-46.

• 3) 佐藤滋ら:心臓外科手術前後の安静時および運動時の呼吸応答に関する検討. 循環器科1998:44(5):169-172.

• 4) 鎌田潤也ら:弁膜疾患の治療とケアポイント. クリニカルナーシングガイド2 心臓(外科・内科). 東京:メディカ出版;1998. p.234-244.

• 5) 鎌田潤也ら:後天性弁膜疾患僧帽弁膜症. 心臓・血管疾患の診療と看護. 東京:メディカ出版;1999. p.104-115.

• 6) 鎌田潤也ら:回復期の心臓リハビリテーション. Heart View 1998;2(2):98-107.

• 7) Kamata J, et al:Electrocardiographic nature of restored sinus rhythm after Cox maze procedure in patients with chronic atrial fibrillation who also had other cardiac surgery. Heart 1997;77(1):50-55.
  pubmed

• 8) Kamata J, et al:Predictors of sinus rhythm restoration after Cox maze procedure concomitant with other cardiac operations. Ann Thorac Surg 1997;64(2):394-398.
  pubmed

P.219 掲載の参考文献

• 1) 川副浩平:僧帽弁疾患 手術. 別府慎太郎編, 心臓病診療プラクティス 6. 弁膜症を考える. 東京:文光堂;1995;p.204-211.

P.225 掲載の参考文献

• 1) Sato Y, et al:Clinical usefulness of the effective regurgitant orifice area determined by transesophageal echocardiography in patients with eccentric aortic regurgitation. J Heart Valve Dis 1997;6(6):580-586.
  pubmed

P.255 掲載の参考文献

• 1) 中澤誠ら:わが国における新生児心疾患の発生状況. 日本小児科学会雑誌1985;90:2578.

• 2) Imai Y, et al:Ventricular function after anatomic repair in patients with atrioventricular discordance. J Thorac Cardiovasc Surg 1995;110:496-503.

P.256 掲載の参考文献

• 1) 石沢栄次:完全大血管転位, 修正大血管転位. 新小児医学大系33, 小児心臓外科学. 東京:中山書店;1981. p.227-242.

• 2) 安藤正彦:先天性心疾患. 村田和彦ら編. 循環器病学. 第2版. 東京:医学書院;1986. p.181-261.

P.259 掲載の参考文献

• 1) Bove EL, et al:Surgical treatment for hypoplastic left heart syndrome. Jpn J Thorac Cardiovasc Surg 1999;47:47-56.
  pubmed

• 2) Ishino K, et al:The modified Norwood procedure for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1999;117:920-930.
  pubmed

• 3) Norwood WI, et al:Experience with operation for hypoplastic left heart syndrome. J Thorac Cardiovasc Surg 1981;82:511-519.
  pubmed

• 4) 角秀秋:新生児開心術の進歩と問題点. Pharma Medica 1995;13:33-41.
  Medical*Online

• 5) Imoto Y, et al:Norwood procedure without circulatory arrest. Ann Thorac Surg 1999;68:559-561.
  pubmed

• 6) Ishizuka T, et al:Bilateral pulmonary artery banding for resuscitation in hypoplastic left heart syndrome. Ann Thorac Surg 2003;75:277-279.

• 7) Masuda M, et al:Clinical results of the staged Fontan procedure in high risk patients. Ann Thorac Surg 1998;63:1721-1725.

• 8) 角秀秋:左心低形成症候群に対するNorwood手術成績向上への提言. 日本小児循環器学会雑誌1998;14(5):614-616.

P.263 掲載の参考文献

• 1) Perloff JK:Ebstein's anomaly of the tricuspid valve. In:The clinical recognition of congenital heart disease. 2nd ed. Philadelphia:WB Saunders;1978. p.239-259.

• 2) Nadas AS, et al:Pediatric cardiology. 3rd ed. Philadelphia;WB Saunders;1972. p.597

• 3) 中澤誠:発生頻度と病型別頻度. 中澤誠編. 先天性心疾患, 目で見る循環器病シリーズ2版, 東京:メジカルビュー;1999. p.2.

• 4) 龍野勝彦:エプスタイン奇形. 永井良三ら編. 循環器研修医ノート. 東京:診断と治療社;1977. p.737-739.

• 5) 川瀧元良:Ebstein奇形, 三尖弁異形性. 中澤誠編. 先天性心疾患, 目で見る循環器病シリーズ2版, 東京:メジカルビュー;1999. p.80-82.

• 6) 高安俊介ら:Ebstein病の手術適応と術式の選択. 心臓1973;5:211-227.

• 7) Sealy WC, et al:Surgical treatment of tachyarrhythmias in patients with both an Ebstein anomaly and a Kent bundle. J Thorac Cardiovasc Surg 1978;75:847-853.

• 8) 三崎拓郎ら. Ebstein病を伴うWPW症候群の外科治療. 日本胸部外科学会雑誌1986;34:1735-1743.

• 9) Pitlick PT, et al:Follow up on a new procedure for Ebstein's anomaly in the critical ill neonate. Circulation 1990;82(Suppl III):716.

• 10) Starnes VA, et al:Ebstein anomaly appearing in the neonate. J Thorac Cardio-vasc Surg 1991;101:1082-1087.

• 11) Danielson GK, et al:Surgical repair of Ebstein's anomaly. Mayo Clin Proc 1979;54:185-192.
  pubmed

• 12) Carpentier A, et al:A new reconstructive operation for Ebstein's anomaly of the tricuspid valve. J Thorac Caridiovasc Surg 1988;96:92-101.

• 13) Cox JL, et al:The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569-583.
  pubmed

P.268 掲載の参考文献

• 1) Anderson RH, et al:Pulmonary stenosis. In:Anderson RH, et al, editors. Paediatric cardiology. London:Churchill Livingstone;1987. p.959-975.

• 2) 松裏裕行ら:カテーテル治療. 中澤誠編, 先天性心疾患. 東京:メジカルビュー社;1999. p.43-55.

• 3) 松本康俊ら:肺動脈弁狭窄. 高尾篤良ら編, 臨床発達心臓病学. 東京:中外医学社;1997. p.512-520.

• 4) 中西敏雄:カテーテル治療. 高尾篤良ら編, 臨床発達心臓病学. 東京:中外医学社;1997. p.248-266.

• 5) 中澤誠:肺動脈弁狭窄. 先天性心疾患. 中澤誠編. 東京:メジカルビュー社;1999, p.258-262.

P.272 掲載の参考文献

• 1) Somerville J:Aortic stenosis and incompetence. In:Anderson RH, et al, editors. Paediatric Cardiology. London:Churchill Livingstone;1987. p.959-975.

• 2) 松裏裕行ら:カテーテル治療. 中澤誠編. 先天性心疾患. 東京:メジカルビュー社;1999. p.43-55.

• 3) 中西敏雄:大動脈弁狭窄. 中澤誠編. 先天性心疾患. 東京:メジカルビュー社;1999. p.242-252.

• 4) 中西敏雄:大動脈弁上狭窄. 中澤誠編. 先天性心疾患. 東京:メジカルビュー社;1999. p.253-257.

• 5) 中西敏雄:大動脈弁狭窄症. 高尾篤良ら編. 臨床発達心臓病学. 東京:中外医学社;1997. p.530-545.

• 6) 中西敏雄:カテーテル治療. 高尾篤良ら編. 臨床発達心臓病学. 東京:中外医学社;1997. p.248-266.

P.277 掲載の参考文献

• 1) Walters HLIII, et al:Congenital heart surgery nomenclature and database project:outlet right ventricle. Ann Thoac Surg 2000;69:S249-S263.

• 2) 川島康生:両大血管右室起始の定義と分類. 日本胸部外科学会誌1981;29:967-971.

• 3) Kirklin JW, et al:Double outlet right ventricle. In:Cardiac surgery. 2nd ed. New York:Churchill Livingstone;1993.

• 4) Lev M, et al:A concept of double-outlet right ventricle. J Thorac Cardiovasc Surg 1972;64:271-281.
  pubmed

• 5) Kirklin JW, et al:Current risks and protocols for operation for double outlet right ventricle. J Thorac Cardiovasc Surg 1986;92:913.
  pubmed

• 6) Walters HLIII, et al:Double outlet right ventricle. In:Pediatric cardiac surgery. 2nd ed. Boston:Mosby;1994.

• 7) Aoki M, et al:Result of biventricular repair for double outlet right ventricle. J Thorac Cardiovasc Surg 1994;107:338.
  pubmed

• 8) Kawashima Y, et al:Intraventricular repair for Taussig-Bing anomaly. J Thorac Cardiovasc Surg 1993;105:591.

• 9) Mavroudis C, et al:Taussig-Bing anomaly:arterial switch versus Kawashima intraventricular repair. Ann Thorac Surg 1996;61:1331-1338

P.291 掲載の参考文献

• 1) Heath D, et al:The pathology of hypertensive pulmonary vascular disease:a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18:533-548.
  pubmed

• 2) 門間和夫:肺高血圧. 新小児医学大系10D, 小児循環器病学IV, 東京:中山書店;1984;p.3-35.

• 3) Yamaki S, et al:Indications for surgery based on lung biopsy in cases of ventricular septal defect and/or patent ductus with severe pulmonary hypertension. Chest 1989;96:31-39.
  pubmed

• 4) Ammash N, et al:Cerebrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol 1996;28:768-772.
  pubmed

• 5) Rosenzweig EB, et al:Long-term prostacyclin for pulmonary hypertension with cyanotic congenital heart defects. Circulation 1999;99:1858-1865.

• 6) Michelakis ED, et al:Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Circulation 2003;108:2066-2069.
  pubmed

• 7) Miller OI, et al:Very-low-dose inhaled nitric oxide:a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg 1994;108:487-494.
  pubmed

• 8) Arcasony SM, et al:Lung transplantation. N Engl J Med 1999;340:1081-1091.

• 9) Brickner ME, et al:Congenital heart disease in adults. N Engl J Med 2000;342:334-342.
  pubmed

• 10) Weiss BM, et al:Outcome of pulmonary vascular disease in pregnancy:a systematic overview from 1978 through 1996. J Am Coll Cardiol 1998;31:1650-1657.
  pubmed

• 11) Perloff JK, et al:Prognosis for patients with Eisenmenger syndrome of various aetiology. Int J Cardiol 1994;45:199-207.

P.298 掲載の参考文献

• 1) 楠元雅子:成人の先天性心疾患. 高尾篤良ら編. 臨床発達心臓病学. 東京:中外医学社;1997. p.117-131.

• 2) Tanaka T, et al:The sinus node and the atrioventricular node function of secundum atrial septal defect in adults. 東京女子医科大学雑誌1987;57:1393-1401.

• 3) 楠元雅子ら:20歳以上のFallot四徴症の臨床的検討―根治術未施行例について. Jpn Circ J 1995;58(Suppl):1260-1264.

• 4) 成人先天性心疾患診療ガイドライン(班長門間和夫). 循環器病の診断と診療に関するガイドライン. Jpn Circ J 2000;64(Suppl IV):1167-1204.

• 5) 星野修一ら:Fallot四徴症根治術後の長期遠隔成績. Jpn Circ J 1995;58(Suppl):1270-1280.

• 6) 石塚尚子:修正大血管転換症. 矢崎義雄編. 循環器NOW9:先天性心疾患・小児の心疾患. 東京:南江堂;1995. p.262-264.

P.310 掲載の参考文献

• 1) Richardson P, et al:Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-842.
  pubmed

• 2) Kimura A, et al:Molecular etiology of idiopathic cardiomyopathy in Asian populations. J Cardiol 2001;37(Suppl I):139-146.

• 3) Keller DI, et al:Genetics of familial cardiomyopathies and arrhythmias. Swiss Med Wkly 2002;132:401-407.
  pubmed

• 4) 竹越襄ら:急性重症心不全治療ガイドライン. Jpn Circ J 2000;64(Suppl IV):1129-1165.

• 5) 松崎益徳ら:慢性心不全治療ガイドライン. Jpn Circ J 2000;64(Suppl IV):1023-1079.

• 6) 河合忠一:心筋症の話. 中公新書1722, 東京:中央公論新社;2003.

• 7) 坂本二哉ら:心尖部肥大型心筋症. 日本臨牀2000;58:93-101.

• 8) 中尾正一郎:心Fabry病. 日本内科学会雑誌2002;91(創立100周年記念号):858-861.

• 9) 寺崎文生ら:拘束型心筋症を知る. 松崎益徳編. 心臓病診療プラクティス11, 心筋症を知る. 東京:文光堂;1996. p.244-255.

• 10) 栗栖智ら:たこつぼ型心筋障害. 日本内科学会雑誌2002;91(創立100周年記念号):849-852.

P.319 掲載の参考文献

• 1) Report of an Expert Committee:Chronic cor pulmonale. WHO Tech Rep Ser 1961;213:1 (Reprint:Circulation 1963;27:594-615).

• 2) The Criteria Committee of NYHA:Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 8th ed. Boston:Little, Brown and Co;1979. p.20-21.

• 3) 国枝武義:肺性心;診断と治療の進歩. 右心カテーテル検査, 日本内科学会雑誌1993;82:824-829.

• 4) Kunieda T, et al:Physiopathology and treatment of chronic cor pulmonale due to dysventilation syndrome. Jpn Circ J 1989;53:1298-1309.
  pubmed

• 5) 国枝武義:肺性心と胸部X線. 呼吸1996;15:52-61.

• 6) 国枝武義:成人肺高血圧症の臨床に関する新知見. 進歩する心臓研究1998;18:83-93.

• 7) 国枝武義ら:TRK-100の原発性肺高血圧症, 膠原病に合併する肺高血圧症に対する臨床試験. 臨床と研究1997;74:2611-2629.

• 8) Okano Y, et al:Orally active prostacyclin analogue in primary pulmonary hypertension. Lancet 1997;349:1365.
  pubmed

• 9) 国枝武義:原発性肺高血圧症治療の進歩, 病態. Cardiac Practice 2004;15:349-356.

• 10) 国枝武義:肺高血圧症の新しい治療. 細田瑳一ら監修. 先端医療シリーズ28. 心臓病, 診断と治療の最前線. 東京:先端医療技術研究所;2004. p.10-16.

P.325 掲載の参考文献

• 1) 宮武邦夫ら:感染性心内膜炎の予防と治療に関するガイドライン. Circ J 2003;67(Suppl IV):1039-1109.

• 2) Bayer AS, et al:Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936-2948.
  pubmed

• 3) Bonow RO, et al:IV. Evaluation and management of infective endocarditis in ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease). J Am Coll Cardiol 1999;32:1541-1545.

• 4) Durack DT, et al:New criteria for diagnosis of infective endocarditis:Utilization of specific endocardiographic findings. Am J Med 1994;96:200-209.

• 5) Dajani AS, et al:Prevention of bacterial endocarditis recommendation by the American Heart Association. Circulation 1997;96:358-366.
  pubmed

P.335 掲載の参考文献

• 1) Lorell BH, et al:Pericardial disease. In:Braunwald E editor. Heart disease. Philadelphia:WB Saunders;1997. p.1478-1534.

• 2) Fowler NO:The pericardium in health and disease. New York:Futura Publishing Co;1985. p.158.

• 3) Yang SS, et al:From cardiac catheterization data to hemodynamic parameter. 3rd ed. Philadelphia:FA Davis Company;1988. p.310.

P.344 掲載の参考文献

• 1) Hall RJ, et al:Cardiac neoplasm. In:Hurst's the heart. New York:McGraw-Hill;1994. p.2295-2318.

• 2) Colucci WS, et al:Primary tumors of the heart. In:Heart disease. Braunwald E editor. Philadelphia:WB Saunders;1997. p.1464-1477.

• 3) Kanda T, et al:Interleukin-6 and cardiac myxoma. Am J Cardiol 1994;74:965-967.
  pubmed

• 4) Reynen K:Cardiac myxoma. New Engl J Med 1995;333(24):1610-1617.
  pubmed

• 5) Casey M, et al:Mutations in the protein kinase A R1 alfa regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest 2000;106:R31-38.

• 6) Roberts WC:Cardiac neoplasms. In:Comprehensive cardiovascular medicine. Topol EJ editor. Philadelphia:Lippincott-Raven Publishers;1998. p.1111-1128.

P.357 掲載の参考文献

• 1) 幕内晴朗:主な心臓血管手術と術後の管理. 内科学I. 東京:文光堂;1999. p.634-640.

• 2) 安達秀雄:大動脈疾患の診断と手術―初期診断から患者管理の実際まで. 東京:メディカル・サイエンス・インターナショナル;1996.

• 3) 国立循環器病センター心臓血管外科部門編:心臓血管外科管理ハンドブック. 東京:南江堂;1995.

• 4) 龍野勝彦:心臓外科エキスパートナーシング. 東京:南江堂;1990.

P.364 掲載の参考文献

• 1) 川崎富作:指趾の特異的落屑を伴う小児の急性熱性皮膚粘膜淋巴腺症候群. アレルギー1967;16:178-222.

• 2) 薗部友良:川崎病の診断と治療. 神谷哲郎編. 東京:日本臨牀社;1994.

• 3) 高橋啓ら:川崎病ハンドブック. 大国真彦ら編. 東京:中外医学社;1988.

• 4) 佐藤登:川崎病. 小児の心エコー図―基礎から最新の臨床応用まで. 加藤裕久編. 東京:金原出版;1993, p.149

• 5) 佐地勉ら:川崎病急性期治療のガイドライン. 日本小児循環器学会雑誌2004;20:54-62.

P.375 掲載の参考文献

• 1) Dormandy JA, et al:Management of peripheral arterial disease. TransAt lantic Inter-Society Consensus(TASC). J Vasc Surg 2000;31(Suppl 1 Pt2):S1-S278.

• 2) 脈管学会編:下肢閉塞性動脈硬化症の診断治療指針. Management of peripheral arterial disease. TransAtlantic-Society Consensus(TASC). 東京:協和企画;2000, p.1-299.

• 3) TransAtlantic Inter-Society Consensus(TASC)ホームページ:http://www.tasc-pad.org/

• 4) 熊倉久夫ほか:閉塞性動脈硬化症の生命予後-危険因子, 合併症, 治療方法との関係. 脈管学2002;42:889-895.

• 5) 熊倉久夫:末梢血管疾患に対する内科治療の有用性と限界. 循環器科2004;56:30-35.

●第4章 循環器救急疾患の対応

P.393 掲載の参考文献

• 1) Williams JF, et al:Guidelines for the evaluation and management of heart failure:report of the ACC/AHA Task force on practice guidelines. Circulation 1995;92:2764-2784.

• 2) Forrester JS, et al:Medical therapy of acute myocardial infarction by application of hemodynamic subsets. N Engl J Med 1976;295:1356-1362.
  pubmed

P.407 掲載の参考文献

• 1) Dallas:Scientific publishing American Heart Association:Advanced cardiac life support 1997-1999:emergency cardiovascular care programs;1997.

• 2) Latto IP, et al:挿管困難の臨床. 黒須吉夫訳. 東京:HBJ出版局;1988.

• 3) 丸川征四郎:酸素療法. 東京:中外医学社;1991.

• 4) 太田宗夫編:必携ACLS心肺蘇生法―技術から教育まで. Emergency Nursing 2004年新春増刊. メデイカ出版.

• 5) 吉田竜介ら:ACLS策定の目的と経緯. 太田宗夫編. 必携ACLS心肺蘇生―技術から教育まで. Emergency Nursing 2004年新春増刊. p.8-16.

• 6) 岡田和夫, 美濃部嶢監:AHA心肺蘇生と救急心血管治療のための国際ガイドライン2000(日本語版). American Heart Association(発売 中山書店);2001.

• 7) 三田村秀雄編:AED(自動式体外除細動器)―社会に拡がる高度な医療. 救急集中治療2003;15:7.

P.415 掲載の参考文献

• 1) Wood MA:Temporary cardiac pacing. In:Ellenbogen KA, et al, editors. Clinical cardiac pacing. Philadelphia:WB Saunders;1995. p.687-700.

• 2) Fisher W, et al:ペーシング療法の実際. 東京:シュプリンガー・フェアラーク東京, 1998. p.125-128.

P.419 掲載の参考文献

• 1) 篠山重威ら:特集 心原性ショック―診断と治療の進歩. 日本内科学会雑誌1996;85:1-87.

• 2) Antman EM:Acute myocardial infarction. In:Braunwald E, editor. Heart disease:a textbook of cardiovascular medicine. 5th ed. Philadelphia:WB Saunders;1998. p.1184-1288.

• 3) Hands ME:AMI:cardiogenic shock. In:Thompson PL, editor. Coronary care manual. New York:Churchill Livingstone;1997. p.473-478.

• 4) ACC/AHA Task Force Report:Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Committee on Evaluation and management of Heart failure). Circulation 1955;92:2764-2784.

P.423 掲載の参考文献

• 1) Lorell BH, et al:Profiles in constrictive pericarditis, restrictive cardiomyopathy, and cardiac tamponade. In:Baim DS, et al, editors. Cardiac catheterization, angiography, and intervention. 5th ed. Baltiomore:Williams & Wilkins;1996, p.801-821.

P.430 掲載の参考文献

• 1) 日本高血圧学会高血圧治療ガイドライン作成委員会:高血圧治療ガイドライン2000年度版. 東京:日本高血圧学会;2000.

• 2) 日本高血圧学会高血圧治療ガイドライン作成委員会:実地医家のための高血圧治療ガイドライン. 東京:日本高血圧学会;2001.

• 3) 樋渡正夫:高血圧性緊急症. 永井良三編, 循環器研修医ノート. 東京:診断と治療社;1997. p.204.

• 4) 大和田隆監修:高血圧性緊急症―病態と治療―. 東京:医科学出版社;1994.

• 5) 冨山博史ら:外来における高血圧性緊急症の診断と対応. Medical Practice:2000;17:859.
  Medical*Online

• 6) Grossmann E, et al:Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996;276:1328.

• 7) 樋渡正夫:脳血管障害者の高血圧. 阿部圭志編, 高血圧の症例と処方. 東京:医薬ジャーナル社;1990. p.66.

• 8) 樋渡正夫:動脈瘤. 阿部圭志ら編, 高血圧の個別治療. 東京:医薬ジャーナル社;1998. p.71.

• 9) National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy:National High Blood Pressure Education Program Working group report on high blood pressure in pregnancy. Am J Obestet Gynecol 1990;163:1689.

●第5章 循環器疾患の管理と治療

P.442 掲載の参考文献

• 1) Stamler J:Episemiologic findings on body mass and blood pressure in adults. Ann Episemiol 1991;1:347-362.
  pubmed

• 2) Reid CM, et al:Interactions between the effects of exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure in overweight subjects. J Hypertens 1994;12:291-301.
  pubmed

• 3) Puddey IB, et al:Effects of alcohol and caloric restrictions on blood pressure and serum lipid in over weight men. Hypertension 1992;20:533-541.
  pubmed

• 4) Whelton PK, et al:Sodium reduction and weight loss in the treatment of hypertension in older persons:a randomized controlled trial of nonpharmacologic interventions in the elderly(TONE). JAMA 1998;279:839-846.

• 5) Arakawa K:Antihypertensive mechanism of exercise. J Hypertens 1993;11:223-229.
  pubmed

• 6) Fagard RH:The role of exercise in blood pressure control:supportive evidence. J Hypertens 1995;13:1223-1227.
  pubmed

• 7) Cutler JA, et al:Randomised controlled trials of sodium reduction:an overview. Am J Clin Nutr 1997;65(2 suppls):643S-651S.

• 8) Ishimitu T, et al:Effects of alcohol intake on organ injuries in normotensive and hypertensive human subjects. Clin Sci 1997;93:541-547.

• 9) 石光俊彦ら:高血圧環境因子の新しい側面. 日本内科学雑誌1999;88:207-216.

• 10) Tanabe T, et al:Unstable angina:changes in the ST-T segment during daily activities such as bathing, eating, defecating and urinating. Jpn Circulation J 1983;47:451-458.

• 11) 田辺晃久ら:不安定狭心症患者における日常動作時のST-T変化;Holter法による検討を中心に. 心電図1983;3:61-69.

• 12) 城戸ひとみら:急性心筋梗塞患者の早期リハビリテーションにおける安全性と看護婦の役割. 第13回日本看護学会集録集1982. p49.

P.453 掲載の参考文献

• 1) Shapiro W:Correlative studies of serum digitalis levels and the arrhythmias of digitalis intoxication. Am J Cardiol 1978;41:852-859.
  pubmed

• 2) Williams VEM:A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984;24:129-147.

• 3) Pitt B, et al:Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure:randomized trial;the Losartan Heart failure Survival Study ELITE II. Lanset 2000;355:1582-1587.

• 4) MacKelvie RS, et al:Comparison of candesartan, enalapril, and their combination in congestive heart failure. Circulation 1999;100:1056-1064.

• 5) Hirsh J:Optimal intensity and monitoring warfarin. Am J Cardiol 1995;75:39B-42B.
  pubmed

P.460 掲載の参考文献

• 1) Ryan TJ, et al:Guidelines for percutaneous transluminal coronary angioplasty. Circulation 1988;78:486-502.
  pubmed

• 2) Ryan TJ, et al:Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1993;22:2033-2054.

• 3) 藤原久義ら:冠動脈疾患におけるインターベンション治療の適応ガイドライン(冠動脈バイパス術を含む)―待機的インターベンション. 1998-1999年度合同研究班報告. Jpn Circ J 2000;64(Suppl 4):1009-1022.

• 4) Serruys PW, et al:A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495.
  pubmed

• 5) Fischman DL, et al:A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501.
  pubmed

P.471 掲載の参考文献

• 1) 小坂井嘉夫:植え込み型除細動器. 比江嶋一昌編, Practical Seminar不整脈. 東京:日本医事新報社;2000. p.141-150.

• 2) Gregoratos G, et al:ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices:executive summary. Circulation 1998;97:1325-1335.

• 3) Bernstein AD, et al:The NASPE/BPEG generic pacemaker code for antibrad-yarrhythmia and adaptive-rate pacing and anti-tachyarrhythmia devices. PACE 1987;10:794-799.

• 4) Andersen HR, et al:Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome. Lancet 1994;344:1523-1528.
  pubmed

• 5) The Antiarrhythmics Vs Implantable Defibrillator(AVID)Investigators:A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resusciated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576.

P.484 掲載の参考文献

• 1) 日本心身医学会教育研修委員会編:心身医学の新しい診療指針. 心身医学1991;31:537-576.

• 2) Jiang W, et al:Mental stress-induced myocardial ischemia and cardiac events. JAMA 1996;275:1651-1656.
  pubmed

• 3) 志賀剛:研究班中間報告;情動負荷試験(mirror drawing test). 第54回循環器心身医学研究会会合記録. 1999. p.25-27.

• 4) Rosenman RH, et al:A predictive study of coronary heart disease. The Western Collaborative Group Study. JAMA 1964;189:103-110.

• 5) The Fifth Report of the Joint National Committee on detection:evaluation, and treatment of high blood pressure. Arch Intern Med 1993;153:154-183.
  pubmed